Gert H. Richardt

Gert H. Richardt's AcademicInfluence.com Rankings

Gert H. Richardt

Engineering

#6302

World Rank

#7619

Historical Rank

Biomedical Engineering

#547

World Rank

#557

Historical Rank

engineering Degrees

Gert H. Richardt

Philosophy

#8585

World Rank

#11995

Historical Rank

Logic

#5618

World Rank

#7030

Historical Rank

philosophy Degrees

Download Badge

Engineering
Philosophy

Gert H. Richardt's Degrees

Doctorate Medicine University of California, San Francisco
PhD Biomedical Engineering Stanford University

Why Is Gert H. Richardt Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Gert H. Richardt's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. (1996) (1687)
Intraaortic balloon support for myocardial infarction with cardiogenic shock. (2012) (1643)
Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. (2013) (758)
Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial (2013) (686)
Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. (2011) (659)
Comparison of zotarolimus-eluting and everolimus-eluting coronary stents. (2010) (655)
Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk. (2015) (638)
A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placem (2012) (617)
Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. (2014) (598)
Aortic regurgitation after transcatheter aortic valve implantation: incidence and early outcome. Results from the German transcatheter aortic valve interventions registry (2011) (502)
Circadian Profile of Cardiac Autonomic Nervous Modulation in Healthy Subjects: (2003) (468)
Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes. (2019) (435)
Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. (1995) (403)
High-speed rotational atherectomy before paclitaxel-eluting stent implantation in complex calcified coronary lesions: the randomized ROTAXUS (Rotational Atherectomy Prior to Taxus Stent Treatment for Complex Native Coronary Artery Disease) trial. (2013) (376)
A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent:the SPIRIT II trial. (2006) (368)
Bivalirudin versus unfractionated heparin during percutaneous coronary intervention. (2008) (344)
Fractional Flow Reserve‐Guided Multivessel Angioplasty in Myocardial Infarction (2017) (323)
Four‐Year Experience With Palmaz‐Schatz Stenting in Coronary Angioplasty Complicated by Dissection With Threatened or Present Vessel Closure (1994) (293)
Treatment and Clinical Outcomes of Transcatheter Heart Valve Thrombosis (2015) (256)
Anatomic and procedural predictors of paravalvular aortic regurgitation after implantation of the Medtronic CoreValve bioprosthesis. (2010) (249)
5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions. (2010) (240)
A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg–Strauss, EGPA): monocentric experiences in 150 patients (2012) (227)
Validation of the Bleeding Academic Research Consortium Definition of Bleeding in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (2012) (219)
Cardioprotective effects of the Na(+)/H(+) exchange inhibitor cariporide in patients with acute anterior myocardial infarction undergoing direct PTCA. (2000) (217)
Adenosine inhibits exocytotic release of endogenous noradrenaline in rat heart: a protective mechanism in early myocardial ischemia. (1987) (212)
Nonexocytotic release of endogenous noradrenaline in the ischemic and anoxic rat heart: mechanism and metabolic requirements. (1987) (200)
Iyengar Yoga Increases Cardiac Parasympathetic Nervous Modulation Among Healthy Yoga Practitioners (2007) (192)
Arterial Revascularisation Therapies Study Part II - Sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions. (2005) (189)
Comparison of a Novel Biodegradable Polymer Sirolimus-Eluting Stent With a Durable Polymer Everolimus-Eluting Stent: Results of the Randomized BIOFLOW-II Trial (2015) (176)
Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): a randomised controlled superiority trial (2011) (170)
Clinical Bioprosthetic Heart Valve Thrombosis After Transcatheter Aortic Valve Replacement: Incidence, Characteristics, and Treatment Outcomes. (2017) (163)
4-year clinical outcomes and predictors of repeat revascularization in patients treated with new-generation drug-eluting stents: a report from the RESOLUTE All-Comers trial (A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutaneous Coronary Intervention (2014) (152)
A randomized, prospective, intercontinental evaluation of a bioresorbable polymer sirolimus-eluting coronary stent system: the CENTURY II (Clinical Evaluation of New Terumo Drug-Eluting Coronary Stent System in the Treatment of Patients with Coronary Artery Disease) trial (2014) (146)
Time Course of Restenosis During the First Year After Emergency Coronary Stenting (1993) (140)
Activation of β-Adrenergic Receptor Kinase During Myocardial Ischemia (1996) (137)
High-Speed Rotational Atherectomy Versus Modified Balloons Prior to Drug-Eluting Stent Implantation in Severely Calcified Coronary Lesions: The Randomized PREPARE-CALC Trial (2018) (133)
1-Year Outcomes After Transcatheter Aortic Valve Replacement With Balloon-Expandable Versus Self-Expandable Valves: Results From the CHOICE Randomized Clinical Trial. (2015) (133)
Catecholamine release and arrhythmias in acute myocardial ischaemia. (1991) (132)
Comparison of outcomes in patients having isolated transcatheter aortic valve implantation versus combined with preprocedural percutaneous coronary intervention. (2012) (131)
Comparison of Zotarolimus- and Everolimus-Eluting Coronary Stents (2015) (130)
Simvastatin Acutely Reduces Myocardial Reperfusion Injury In Vivo by Activating the Phosphatidylinositide 3-Kinase/Akt Pathway (2004) (123)
Regional in vivo and in vitro characterization of autonomic innervation in cardiomyopathic human heart. (1998) (113)
Neuronal sodium homoeostatis and axoplasmic amine concentration determine calcium-independent noradrenaline release in normoxic and ischemic rat heart. (1988) (111)
The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial. (2011) (111)
The impact of patient and lesion complexity on clinical and angiographic outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial (a randomized comparison of a zotarolimus-eluting stent with an everolimus-eluting stent for percutan (2011) (109)
Admission Troponin T Level Predicts Clinical Outcomes, TIMI Flow, and Myocardial Tissue Perfusion After Primary Percutaneous Intervention for Acute ST-Segment Elevation Myocardial Infarction (2001) (105)
Efficacy of everolimus eluting stent implantation in patients with calcified coronary culprit lesions: Two‐year angiographic and three‐year clinical results from the SPIRIT II study (2010) (105)
Long‐term clinical outcome of rotational atherectomy followed by drug‐eluting stent implantation in complex calcified coronary lesions (2013) (104)
Prasugrel plus bivalirudin vs. clopidogrel plus heparin in patients with ST-segment elevation myocardial infarction. (2014) (100)
Haemodynamic evaluation of aortic regurgitation after transcatheter aortic valve implantation using cardiovascular magnetic resonance. (2011) (98)
Comparison of hospital mortality with intra-aortic balloon counterpulsation insertion before versus after primary percutaneous coronary intervention for cardiogenic shock complicating acute myocardial infarction. (2010) (92)
5-Year Outcomes After TAVR With Balloon-Expandable Versus Self-Expanding Valves: Results From the CHOICE Randomized Clinical Trial. (2020) (91)
Regional patterns of myocardial sympathetic denervation in dilated cardiomyopathy: an analysis using carbon-11 hydroxyephedrine and positron emission tomography (1999) (90)
Randomized Comparison of Ticagrelor versus Prasugrel in Patients with Acute Coronary Syndrome and Planned Invasive Strategy—Design and Rationale of the Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT) 5 Trial (2014) (88)
Outcomes of cardiac rehabilitation with versus without a follow-up intervention rendered by telephone (Luebeck follow-up trial): overall and gender-specific effects (2006) (88)
Drug-eluting stents versus bare metal stents following rotational atherectomy for heavily calcified coronary lesions: late angiographic and clinical follow-up results. (2007) (87)
Rotational atherectomy before paclitaxel‐eluting stent implantation in complex calcified coronary lesions: Two‐year clinical outcome of the randomized ROTAXUS trial (2016) (86)
Incidence and predictors of target vessel revascularization and clinical event rates of the sirolimus-eluting coronary stent (results from the prospective multicenter German Cypher Stent Registry). (2005) (85)
Acute Reduction of Myocardial Infarct Size By a Hydroxymethyl Glutaryl Coenzyme A Reductase Inhibitor Is Mediated by Endothelial Nitric Oxide Synthase (2003) (83)
Multi-vessel stenting during primary percutaneous coronary intervention for acute myocardial infarction (2007) (83)
Course and prognostic implications of QT interval and QT interval variability after primary coronary angioplasty in acute myocardial infarction. (2001) (82)
Emergency endovascular stent-grafting for life-threatening acute type B aortic dissections. (2004) (80)
Incidence and predictors of permanent pacemaker implantation following transcatheter aortic valve implantation: Analysis from the german transcatheter aortic valve interventions registry (2013) (77)
Cardiac sympathetic activity in myocardial ischemia: release and effects of noradrenaline. (1990) (77)
Rotational atherectomy followed by drug-eluting stent implantation (Rota-DES): a rational approach for complex calcified coronary lesions. (2008) (76)
Transcatheter aortic valve implantation in patients with and without concomitant coronary artery disease: comparison of characteristics and early outcome in the German multicenter TAVI registry (2012) (75)
The impact of peripheral arterial disease on early outcome after transcatheter aortic valve implantation: results from the German Transcatheter Aortic Valve Interventions Registry. (2012) (71)
Extracorporeal cardiac shock wave therapy: first experience in the everyday practice for treatment of chronic refractory angina pectoris. (2007) (71)
Zotarolimus- versus everolimus-eluting stents for unprotected left main coronary artery disease. (2013) (69)
Aortic regurgitation after transcatheter aortic valve implantation with balloon- and self-expandable prostheses: a pooled analysis from a 2-center experience. (2014) (68)
No evidence of "obesity paradox" after treatment with drug-eluting stents in a routine clinical practice: results from the prospective multicenter German DES.DE (German Drug-Eluting Stent) Registry. (2012) (64)
Two different mechanisms of noradrenaline release during normoxia and simulated ischemia in human cardiac tissue. (1995) (63)
Bivalirudin vs. unfractionated heparin during percutaneous coronary interventions in patients with stable and unstable angina pectoris: 1-year results of the ISAR-REACT 3 trial. (2010) (63)
Long-term durability and haemodynamic performance of a self-expanding transcatheter heart valve beyond five years after implantation: a prospective observational study applying the standardised definitions of structural deterioration and valve failure. (2018) (62)
Stuck rotablator: the nightmare of rotational atherectomy. (2013) (61)
Sympatho-adrenergic activation of the ischemic myocardium and its arrhythmogenic impact. (1995) (61)
Prognostic Value of Access and Non–Access Sites Bleeding After Percutaneous Coronary Intervention (2013) (57)
Bioprosthetic Valve Performance After Transcatheter Aortic Valve Replacement With Self-Expanding Versus Balloon-Expandable Valves in Large Versus Small Aortic Valve Annuli: Insights From the CHOICE Trial and the CHOICE-Extend Registry. (2018) (57)
1-year outcome of TRIAS HR (TRI-stent adjudication study-high risk of restenosis) a multicenter, randomized trial comparing genous endothelial progenitor cell capturing stents with drug-eluting stents. (2011) (56)
Heart rate variability in patients with acute myocardial infarction undergoing primary coronary angioplasty. (2000) (56)
Gender differences in patients with cardiogenic shock complicating myocardial infarction: a substudy of the IABP-SHOCK II-trial (2014) (55)
Aortic Regurgitation and Left Ventricular Remodeling After Transcatheter Aortic Valve Implantation: A Serial Cardiac Magnetic Resonance Imaging Study (2013) (51)
Reflex Cardiac Activity in Ischemia and Reperfusion: Heart Rate Turbulence in Patients Undergoing Direct Percutaneous Coronary Intervention for Acute Myocardial Infarction (2003) (51)
Three-year follow-up of the ARTS-II# - sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease. (2008) (50)
Risk Stratification in Patients With Inferior Acute Myocardial Infarction Treated by Percutaneous Coronary Interventions: The Role of Admission Troponin T (2000) (49)
Effect of myocardial ischemia on stimulation-evoked noradrenaline release. Modulated neurotransmission in rat, guinea pig, and human cardiac tissue. (1993) (48)
Profile of bleeding and ischaemic complications with bivalirudin and unfractionated heparin after percutaneous coronary intervention. (2008) (48)
Clinical Valve Thrombosis After Transcatheter Aortic Valve-in-Valve Implantation (2018) (46)
Circadian Profile of QT Interval and QT Interval Variability in 172 Healthy Volunteers (2003) (46)
Bleeding after percutaneous coronary intervention in women and men matched for age, body mass index, and type of antithrombotic therapy. (2013) (45)
Efficacy Over Time With Drug-Eluting Stents in Saphenous Vein Graft Lesions. (2018) (44)
Transient ischemia reduces norepinephrine release during sustained ischemia. Neural preconditioning in isolated rat heart. (1996) (44)
Activation of beta-adrenergic receptor kinase during myocardial ischemia. (1996) (44)
Twelve-month results of a paclitaxel releasing balloon in patients presenting with in-stent restenosis First-in-Man (PEPPER) trial. (2012) (40)
Characterization and presynaptic modulation of stimulation-evoked exocytotic co-release of noradrenaline and neuropeptide Y in guinea pig heart (2004) (40)
Incidence, feasibility and outcome of percutaneous coronary intervention after transcatheter aortic valve implantation with a self-expanding prosthesis. Results from a single center experience. (2016) (40)
Impact of aortic valve calcification on the outcome of transcatheter aortic valve implantation: Results from the prospective multicenter German TAVI registry (2013) (40)
The Role of Catecholamines in Ischemia (1990) (39)
Effect of gender differences on 1-year mortality after transcatheter aortic valve implantation for severe aortic stenosis: results from a multicenter real-world registry (2014) (39)
Sodium-hydrogen exchange inhibition: novel strategy to prevent myocardial injury following ischemia and reperfusion. (1999) (39)
Apstatin, a selective inhibitor of aminopeptidase P, reduces myocardial infarct size by a kinin‐dependent pathway (2001) (38)
Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry). (2009) (37)
Early hemodynamic and neurohormonal response after transcatheter aortic valve implantation. (2010) (37)
Adenosine inhibits norepinephrine release in the postischemic rat heart: the mechanism of neuronal stunning. (2001) (37)
Performing and Interpreting Fractional Flow Reserve Measurements in Clinical Practice: An Expert Consensus Document. (2017) (37)
One-year outcomes with two suture-mediated closure devices to achieve access-site haemostasis following transfemoral transcatheter aortic valve implantation. (2016) (37)
Temporal repolarization inhomogeneity and reperfusion arrhythmias in patients undergoing successful primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: impact of admission troponin T. (2003) (36)
Real-world experience with a novel biodegradable polymer sirolimus-eluting stent: twelve-month results of the BIOFLOW-III registry. (2016) (36)
Intravenous thrombolytic therapy with a combination of single-chain urokinase-type plasminogen activator and recombinant tissue-type plasminogen activator in acute myocardial infarction. (1990) (36)
Effect of digitalis glycosides on norepinephrine release in the heart. Dual mechanism of action. (1991) (35)
Ticagrelor or Prasugrel in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes. (2020) (34)
Coronary Palmaz-Schatz stent implantation in acute myocardial infarction. (1996) (34)
Myocardial infarction associated with ovarian hyperstimulation syndrome. (1999) (33)
Ticagrelor or Prasugrel in Patients With Acute Coronary Syndromes and Diabetes Mellitus. (2020) (33)
Accelerated Idioventricular Rhythm in the Post‐thrombolytic Era: Incidence, Prognostic Implications, and Modulating Mechanisms after Direct Percutaneous Coronary Intervention (2005) (33)
High incidence of sudden death late after anterior LV-aneurysm repair. (2004) (33)
Impaired coronary flow and left ventricular dysfunction after mechanical recanalization in acute myocardial infarction: role of neurohumoral activation? (2002) (33)
Sirolimus-eluting stents, bare metal stents or coronary artery bypass grafting for patients with multivessel disease including involvement of the proximal left anterior descending artery: analysis of the Arterial Revascularization Therapies study part 2 (ARTS-II) (2009) (33)
A Novel Angiographic Quantification of Aortic Regurgitation After TAVR Provides an Accurate Estimation of Regurgitation Fraction Derived From Cardiac Magnetic Resonance Imaging. (2018) (32)
Drug-coated versus bare-metal stents for elderly patients: A predefined sub-study of the LEADERS FREE trial. (2017) (31)
Role of calcium channels and protein kinase C for release of norepinephrine and neuropeptide Y. (1990) (31)
Endogenous adenosine reduces the occurrence of ischemia-induced ventricular fibrillation in rat heart. (1999) (30)
Predictors of death or myocardial infarction during follow-up after coronary stenting with the sirolimus-eluting stent. Results from the prospective multicenter German Cypher Stent Registry. (2006) (30)
Interaction between the release of adenosine and noradrenaline during sympathetic stimulation: a feed-back mechanism in rat heart. (1989) (30)
Prognostic significance of admission cardiac troponin T in patients treated successfully with direct percutaneous interventions for acute ST-segment elevation myocardial infarction* (2002) (30)
U73122, an Aminosteroid Phospholipase C Inhibitor, Is a Potent Inhibitor of Cardiac Phospholipase D by a PIP2-Dependent Mechanism (2010) (30)
Longitudinal deformation of contemporary coronary stents: an integrated analysis of clinical experience and observations from the bench. (2012) (30)
“Real life” use of sirolimus-eluting coronary stents in Germany (2004) (29)
Coronary artery treatment with paclitaxel-coated balloon using a BTHC excipient: clinical results of the international real-world DELUX registry. (2014) (29)
Age- and Weight-Adapted Dose of Prasugrel Versus Standard Dose of Ticagrelor in Patients With Acute Coronary Syndromes (2020) (29)
Impact of prosthesis‐iteration evolution and sizing practice on the incidence of prosthesis–patient mismatch after transcatheter aortic valve replacement (2018) (29)
Coronary Access After TAVR With a Self-Expanding Bioprosthesis: Insights From Computed Tomography. (2020) (29)
Evaluation of the short- and long-term safety and therapy outcomes of the everolimus-eluting bioresorbable vascular scaffold system in patients with coronary artery stenosis: Rationale and design of the German-Austrian ABSORB RegIstRy (GABI-R). (2016) (28)
Alpha 1-adrenergic receptor-mediated increase in the mass of phosphatidic acid and 1,2-diacylglycerol in ischemic rat heart. (1999) (28)
Role of Neuronal KATP Channels and Extraneuronal Monoamine Transporter on Norepinephrine Overflow in a Model of Myocardial Low Flow Ischemia (2004) (28)
Nicotine-induced release of noradrenaline and neuropeptide Y in guinea pig heart. (1988) (28)
Very early cardiac magnetic resonance imaging for quantification of myocardial tissue perfusion in patients receiving tirofiban before percutaneous coronary intervention for ST-elevation myocardial infarction. (2005) (28)
Differential presynaptic modulation of noradrenaline release in human atrial tissue in normoxia and anoxia (1996) (28)
Predictors of 1-year mortality in patients with aortic regurgitation after transcatheter aortic valve implantation: an analysis from the multicentre German TAVI registry (2014) (28)
Angiographic and clinical performance of a paclitaxel-coated balloon compared to a second-generation sirolimus-eluting stent in patients with in-stent restenosis: the BIOLUX randomised controlled trial. (2018) (28)
Nonexocytotic noradrenaline release and ventricular fibrillation in ischemic rat hearts (1995) (28)
Influence of alpha- and beta-adrenoceptor antagonists on ventricular fibrillation in ischemic rat hearts (1997) (28)
Impact of Infarct-Related Artery Flow on QT Dynamicity in Patients Undergoing Direct Percutaneous Coronary Intervention for Acute Myocardial Infarction (2003) (27)
Incidence and prognostic value of bleeding after percutaneous coronary intervention in patients older than 75 years of age (2014) (27)
Comparison of Bailout and Planned Rotational Atherectomy for Heavily Calcified Coronary Lesions: A Single‐Center Experience (2017) (27)
Bradykinin B2-receptor-mediated stimulation of exocytotic noradrenaline release from cardiac sympathetic neurons. (1997) (27)
Impact of smoking on the outcome of patients treated with drug-eluting stents: 1-year results from the prospective multicentre German Drug-Eluting Stent Registry (DES.DE) (2011) (26)
Differential effects of defibrillation on systemic and cardiac sympathetic activity (1998) (26)
Long-term safety and efficacy of dual therapy with oral anticoagulation and clopidogrel in patients with atrial fibrillation treated with drug-eluting stents (2013) (26)
The Sirolimus-eluting coronary stent in daily routine practice in Germany: (2007) (26)
Comparison of outcomes in patients with insulin-dependent versus non-insulin dependent diabetes mellitus receiving drug-eluting stents (from the first phase of the prospective multicenter German DES.DE registry). (2010) (26)
Prognosis of patients with atrial fibrillation undergoing percutaneous coronary intervention receiving drug eluting stents (2013) (25)
Effects of intracoronary low-dose enalaprilat as an adjunct to primary percutaneous transluminal coronary angiography in acute myocardial infarction. (2001) (25)
Short- and long-term health related quality-of-life and anginal status of the Arterial Revascularisation Therapies Study part II, ARTS-II; sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease. (2010) (25)
Sirolimus-eluting stent treatment for unprotected versus protected left main coronary artery disease in widespread clinical routine: 6-month and 3-year clinical follow-up results from the prospective multicentre German Cypher Registry (2007) (25)
Angiographic correlates of a positive troponin T test in patients with unstable angina (2001) (24)
Redo TAVI: initial experience at two German centres. (2016) (24)
Clinical outcomes in diabetic and non-diabetic patients with drug-eluting stents: results from the first phase of the prospective multicenter German DES.DE registry (2010) (24)
Acute kidney injury after transcatheter aortic valve implantation: Impact of contrast agents, predictive factors, and prognostic importance in 203 patients with long-term follow-up. (2015) (24)
[Safety and current indications during "real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multicenter German Cypher Registry]. (2004) (23)
Cardiac noradrenaline release accelerates adenosine formation in the ischemic rat heart: role of neuronal noradrenaline carrier and adrenergic receptors. (1994) (23)
Upregulation of cardiac uptake 1 carrier in ischemic and nonischemic rat heart. (1996) (23)
Prognostic value of the modified American College of Cardiology/American Heart Association lesion morphology classification for clinical outcome after sirolimus-eluting stent placement (results of the prospective multicenter German Cypher Registry). (2008) (23)
Changes in Heart Rate, Heart Rate Variability, and Heart Rate Turbulence during Evolving Reperfused Myocardial Infarction (2005) (23)
Effect of gender differences on early and mid-term clinical outcome after percutaneous or surgical coronary revascularisation in patients with multivessel coronary artery disease: insights from ARTS I and ARTS II. (2009) (22)
Biolimus A9 polymer-free coated stents in high bleeding risk patients undergoing complex PCI: evidence from the LEADERS FREE randomised clinical trial. (2018) (22)
Clinical outcomes of the Resolute zotarolimus-eluting stent in patients with in-stent restenosis: 2-year results from a pooled analysis. (2013) (22)
ADP receptor antagonists in patients with acute myocardial infarction complicated by cardiogenic shock: a post hoc IABP-SHOCK II trial subgroup analysis. (2016) (22)
Clinical and angiographic outcome of patients with acute inferior myocardial infarction (2000) (22)
The TeleGuard trial of additional telemedicine care in CAD patients. 2 Morbidity and mortality after 12 months (2008) (22)
Validation of 12-lead tele-electrocardiogram transmission in the real-life scenario of acute coronary syndrome (2006) (21)
A multicenter post‐marketing evaluation of the Elixir DESolve® Novolimus‐eluting bioresorbable coronary scaffold system: First results from the DESolve PMCF study (2018) (21)
Transcatheter aortic valve implantation (TAVI) by centres with and without an on-site cardiac surgery programme: preliminary experience from the German TAVI registry. (2014) (21)
Super High-Pressure Balloon versus Scoring Balloon to Prepare Severely Calcified Coronary Lesions: The ISAR-CALC Randomized Trial. (2020) (21)
Coronary stenting with the sirolimus-eluting stent in clinical practice: final results from the prospective multicenter German Cypher Stent Registry. (2010) (21)
Atrial fibrillation ablation strategies and outcome in patients with heart failure: insights from the German ablation registry (2019) (21)
Sirolimus-Eluting Stent Treatment at High-Volume Centers Confers Lower Mortality at 6-Month Follow-Up: Results From the Prospective Multicenter German Cypher Registry (2009) (20)
Nicotine-induced release of noradrenaline and neuropeptide Y in guinea-pig heart: role of calcium channels and protein kinase C (1991) (20)
Culprit lesion location and outcome in patients with cardiogenic shock complicating myocardial infarction: a substudy of the IABP-SHOCK II-trial (2016) (20)
Comparison of Prasugrel and Bivalirudin vs Clopidogrel and Heparin in Patients With ST‐Segment Elevation Myocardial Infarction: Design and Rationale of the Bavarian Reperfusion Alternatives Evaluation (BRAVE) 4 Trial (2014) (20)
Ticagrelor or Prasugrel in Patients With ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention (2020) (19)
Quantitative Assessment of Acute Regurgitation Following TAVR: A Multicenter Pooled Analysis of 2,258 Valves. (2020) (19)
A case of rotational atherectomy after implantation of the Medtronic CoreValve bioprosthesis (2012) (19)
Long-term clinical outcomes after bioresorbable and permanent polymer drug-eluting stent implantation: final five-year results of the CENTURY II randomised clinical trial. (2018) (19)
Cardiogoniometry as a diagnostic tool in patients with acute coronary syndromes: results of the CGM@ACS trial (2012) (19)
Altered calcium transient and development of hypertrophy in β2‐adrenoceptor overexpressing mice with and without pressure overload (2003) (18)
Comparison of sirolimus eluting stent with bioresorbable polymer to everolimus eluting stent with permanent polymer in bifurcation lesions: Results from CENTURY II trial (2016) (18)
Senges “ Real life ” use of sirolimus-eluting coronary stents in Germany Results from the prospective multi-centre German Cypher Registry (2004) (18)
Determination of haemodynamic significance of intermediate coronary lesions using three-dimensional coronary reconstruction. (2009) (18)
Age-stratified baseline and outcome characteristics of patients undergoing transcatheter aortic valve implantation: results from the German multicenter registry. (2012) (18)
Description of Pantera Lux paclitaxel-releasing balloon and preliminary quantitative coronary angiography (QCA) results at six months in patients with coronary in-stent restenosis. (2011) (18)
Systemic exposure of everolimus after stent implantation: a pharmacokinetic study. (2008) (18)
Differentiated analysis of an everolimus-eluting stent and a paclitaxel-eluting stent among higher risk subgroups for restenosis: results from the SPIRIT II trial. (2008) (18)
Fate and long-term prognostic implications of mitral regurgitation in patients undergoing transcatheter aortic valve replacement. (2019) (17)
Neuropeptide Y differentiates between exocytotic and nonexocytotic noradrenaline release in guinea-pig heart (1989) (17)
Human cardiac phospholipase D activity is tightly controlled by phosphatidylinositol 4,5-bisphosphate. (2004) (17)
Incidence and predictors of target vessel revascularization after sirolimus-eluting stent treatment for proximal left anterior descending artery stenoses among 2274 patients fromthe prospectivemulticenter German Cypher Stent Registry (2007) (17)
Adenosine A1 receptor-mediated inhibition of myocardial norepinephrine release involves neither phospholipase C nor protein kinase C but does involve adenylyl cyclase. (2006) (17)
Comparison of dual antiplatelet therapy versus oral anticoagulation following transcatheter aortic valve replacement: A retrospective single-center registry analysis. (2017) (16)
Catheter-induced dissection of the left main coronary artery, the nemesis of an invasive cardiologist (2002) (16)
Diazepam versus fentanyl for premedication during percutaneous coronary intervention: results from the Myocardial Protection by Fentanyl during Coronary Intervention (PROFIT) Trial. (2008) (16)
Presynaptic Effects of Moxonidine in Isolated Buffer Perfused Rat Hearts: Role of Imidazoline-1 Receptors and α2-Adrenoceptors (2002) (15)
Calcium Antagonism and Norepinephrine Release in Myocardial Ischemia (1992) (15)
Intracoronary enalaprilat during angioplasty for acute myocardial infarction: alleviation of postischaemic neurohumoral and inflammatory stress? (2007) (15)
Differential effects of carvedilol on norepinephrine release in normoxic and ischemic heart. (2000) (15)
One-year outcomes in 1,010 unselected patients treated with the PROMUS Element everolimus-eluting stent: the multicentre PROMUS Element European Post-Approval Surveillance Study. (2015) (15)
Treatment of in-stent restenosis with sirolimus-eluting-stents: results from the prospective German Cypher stent registry (2008) (15)
Everolimus-eluting bioresorbable scaffolds in patients with coronary artery disease: results from the German-Austrian ABSORB RegIstRy (GABI-R). (2017) (15)
The Natural History of Nonculprit Lesions in STEMI: An FFR Substudy of the Compare-Acute Trial. (2020) (14)
Cardiac release of chemoattractants after ischaemia induced by coronary balloon angioplasty. (1993) (14)
Surgical interventions after emergency endovascular stent-grafting for acute type B aortic dissections. (2007) (14)
Comparative efficacy of two paclitaxel-coated balloons with different excipient coatings in patients with coronary in-stent restenosis: A pooled analysis of the Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In-Stent Restenosis 3 and 4 (ISAR-DESIRE 3 and (2018) (14)
Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction: 3-year follow-up with cost benefit analysis of the Compare-Acute trial. (2020) (14)
Adrenergic activation of cardiac phospholipase D: role of α1-adrenoceptor subtypes (2002) (14)
The TeleGuard trial of additional telemedicine care in CAD patients. 1 Utilization of the system (2008) (14)
Calcium antagonists and cardiac noradrenaline release in ischemia. (1991) (13)
Comparison of carvedilol and metoprolol in patients with acute myocardial infarction undergoing primary coronary intervention (2006) (13)
Feasibility and clinical outcome of rotational atherectomy in patients presenting with an acute coronary syndrome (2018) (13)
Emergency endovascular stent-grafting for life-threatening acute type B aortic dissections (2004) (13)
Long-term clinical outcome of thin-strut cobalt-chromium stents in the drug-eluting stent era: results of the COBALT (comparison of bare-metal stents in all-comers' lesion treatment) registry. (2011) (13)
Quantitative aortography for assessing aortic regurgitation after transcatheter aortic valve implantation: results of the multicentre ASSESS-REGURGE Registry. (2019) (13)
Long-term follow-up after coronary stenting with the sirolimus-eluting stent in clinical practice: results from the prospective multi-center German Cypher Stent Registry (2012) (13)
[Retrograde type A dissection after endovascular stent grafting of type B dissection]. (2002) (12)
Nonexocytotic noradrenaline release induced by pharmacological agents or anoxia in human cardiac tissue (1996) (12)
Very late thrombosis observed on optical coherence tomography 22 months after the implantation of a polymer-based bioresorbable vascular scaffold. (2015) (12)
Comparison between on-label versus off-label use of drug-eluting coronary stents in clinical practice: results from the German DES.DE-Registry (2011) (12)
A HPLC-fluorescence detection method for determination of cardiac phospholipase D activity in vitro. (2000) (12)
Radiofrequency Ablation Of Typical Atrial Flutter Via Right Subclavian/jugular Vein Access In A Patient With Implanted Filter In The Inferior Vena Cava (2009) (12)
Predictors of mortality in patients with cardiogenic shock treated with primary percutaneous coronary intervention and intra-aortic balloon counterpulsation (2016) (12)
Impact of body mass index on the one-year clinical outcome of patients undergoing multivessel revascularization with sirolimus-eluting stents (from the Arterial Revascularization Therapies Study Part II). (2008) (12)
Incidence and impact on prognosis of bleeding during percutaneous coronary interventions in patients with chronic kidney disease (2013) (12)
Transfemoral TAVI devices: design overview and clinical outcomes. (2015) (12)
Effect of sex differences on one-year mortality after transcatheter aortic valve implantation for severe aortic stenosis: results from a multi-centre real-world registry (2013) (12)
Relationship between therapeutic time intervals and intermediate term left ventricular systolic function in patients treated with facilitated percutaneous coronary intervention for acute myocardial infarction (2007) (12)
TCT-328 FFR-guided complete revascularization during primary PCI: Preliminary data from the COMPARE ACUTE trial (2014) (11)
Randomized, Double Blind Trial of 6 Versus 12 Months Of Dual Antiplatelet Therapy After DES-Implantation (ISAR-SAFE) (2014) (11)
Systemic and cardiac catecholamines during elective PTCA and during immediate PTCA for acute myocardial infarction (1997) (11)
951-72 Intravascular Ultrasound Guided Optimized Emergency Coronary Palmaz Schatz Stent Placement without Post Procedural Systemic Anticoagulation (1995) (11)
Norepinephrine release is reduced in cardiac tissue of Type 2 diabetic patients (2003) (11)
Clinical outcomes of different first- and second-generation drug-eluting stents in routine clinical practice: results from the prospective multicenter German DES.DE registry (2013) (11)
The effects of facilitated primary PCI by guide wire on procedural and clinical outcomes in acute ST-segment elevation myocardial infarction (2007) (10)
Propranolol inhibits nonexocytotic noradrenaline release in myocardial ischemia (2004) (10)
Five-year results of the BIOFLOW-III Registry: Real-world experience with a biodegradable polymer sirolimus-eluting stent. (2019) (10)
Comparison of twelve-month outcomes after percutanous coronary intervention with everolimus-eluting versus zotarolimus-eluting or sirolimus-eluting stents from the PROENCY (PROmus ENdeavor CYpher) registry. (2012) (10)
Long-Term Prognostic Impact of Restenosis of the Unprotected Left Main Coronary Artery Requiring Repeat Revascularization. (2020) (10)
High-speed rotational atherectomy of the left main coronary artery: a single-center experience in 50 high-risk patients. (2015) (10)
Release and effects of catecholamines in myocardial ischemia (1990) (9)
Sodium-hydrogen exchange inhibition (1999) (9)
Impact of Lesion Preparation Technique on Side Branch Compromise in Calcified Coronary Bifurcations: A Subgroup Analysis of the PREPARE-CALC Trial (2020) (9)
Polymer-free drug-coated coronary stents in diabetic patients at high bleeding risk: a pre-specified sub-study of the LEADERS FREE trial (2018) (9)
Design and rationale of the COMPARE‐ACUTE trial: Fractional flow reserve–guided primary multivessel percutaneous coronary intervention to improve guideline indexed actual standard of care for treatment of ST‐elevation myocardial infarction in patients with multivessel coronary disease (2017) (9)
Endogenous adenosine suppresses norepinephrine-induced ventricular arrhythmias in rat heart (1998) (9)
Plasma catecholamines and N-terminal proBNP in patients with acute myocardial infarction undergoing primary angioplasty (2003) (9)
Inhibition of nonexocytotic norepinephrine release by desipramine reduces myocardial infarction size. (2006) (9)
Ticagrelor or Prasugrel for Patients With Acute Coronary Syndrome Treated With Percutaneous Coronary Intervention: A Prespecified Subgroup Analysis of a Randomized Clinical Trial. (2021) (8)
Risk factors for clinical events at 1-year follow-up after drug-eluting stent implantation: results from the prospective multicenter German DES.DE registry (2014) (8)
Neurohumoral activation in percutaneous coronary interventions: apropos of ten vasoactive substances during and immediately following coronary rotastenting. (2001) (8)
Optical Coherence Tomography Assessment in Patients Treated With Rotational Atherectomy Versus Modified Balloons (2021) (8)
Update on transcatheter aortic valve replacement. (2015) (8)
Intracoronary Gallopamil During Percutaneous Transluminal Coronary Angioplasty (1992) (8)
Plaque characteristics of nonobstructive coronary lesions in diabetic patients: an intravascular ultrasound virtual histology analysis (2010) (8)
Ischemia-induced ventricular fibrillation in isolated perfused rat heart: role of alpha1A-adrenoceptor mediated activation of protein kinase C (2001) (8)
Safety and Efficacy of Left Atrial Appendage Closure with the Amplatzer Cardiac Plug in Very High Stroke and Bleeding Risk Patients with Non-Valvular Atrial Fibrillation (2015) (8)
Impairment of Presynaptic α2-Adrenoceptor-Regulated Norepinephrine Overflow in Failing Hearts from Zucker Diabetic Fatty Rats (2006) (8)
In Vivo Stent Frame Infolding of a Self-Expanding Transcatheter Aortic Valve After Resheathing. (2018) (8)
A fatal attraction: eosinophils and the heart. (2013) (8)
[Diagnosis of cardiac causes of cerebral embolism: a contribution to 2D echocardiography and long-term ECG]. (1989) (7)
Presynaptic Regulation of Norepinephrine Release in a Model of Nonfailing Hypertrophied Myocardium (2003) (7)
Impact of femoral artery puncture using digital subtraction angiography and road mapping on vascular and bleeding complications after transfemoral transcatheter aortic valve implantation. (2017) (7)
Relationship between cardiovascular risk as predicted by established risk scores and coronary artery plaque composition as detected by virtual histology intravascular ultrasound analysis: the PREDICT pilot study. (2008) (7)
Safety and efficacy of the cobalt chromium PRO-Kinetik coronary stent system: results of the MULTIBENE study. (2012) (7)
Incidence and predictors of unplanned non-target lesion revascularisation up to three years after drug-eluting stent implantation: insights from a pooled analysis of the RESOLUTE Global Clinical Trial Program. (2016) (7)
Long-Term Clinical Outcome of Early Generation Versus New-Generation Drug-Eluting Stents in 481 Patients Undergoing Rotational Atherectomy: A Retrospective Analysis (2017) (7)
Coexistence of factor V Leiden and primary antiphospholipid syndrome: a patient with recurrent myocardial infarctions and thrombocytopenia (2000) (7)
Safety of bivalirudin in patients with coronary artery disease (2012) (7)
CRT-156 Two Year Safety And Clinical Performance Of The Drug Eluting Orsiro Stent In The Treatment Of Subjects With Single De Novo Coronary Artery Lesions (BIOFLOW-II) (2015) (7)
Rationale and design of the MULTISTARS AMI Trial: A randomized comparison of immediate versus staged complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease. (2020) (7)
Intracoronary beta‐brachytherapy in chronic total occlusions: A subgroup analysis from the RENO registry (2003) (7)
Balloon- or Self-Expandable TAVI: Clinical Equipoise? (2015) (7)
Low Doses of Intracoronary Enalaprilat Suppress Reperfusion‐Associated Ventricular Arrhythmias after Primary Percutaneous Coronary Interventions for Acute Myocardial Infarction (2007) (7)
Relationship between peri-strut low intensity areas and vascular healing response after everolimus-eluting bioresorbable scaffold implantation: An optical coherence tomography study. (2017) (7)
Endovascular stent-graft implantation in acute traumatic aortic dissection with contained rupture and hemorrhagic shock (2004) (7)
Presynaptic Regulation of Cardiac Norepinephrine Release in Ischemia (2001) (7)
Transcatheter aortic valve implantation in patients with severely reduced left ventricular systolic function: a single-center experience (2014) (6)
Carvedilol Versus Metoprolol in Patients Undergoing Direct Percutaneous Coronary Interventions for Myocardial Infarction: Effects on QT Dynamicity (2005) (6)
Predictors of early scaffold thrombosis: results from the multicenter prospective German–Austrian ABSORB RegIstRy (2018) (6)
Rotational Atherectomy or Balloon-Based Techniques to Prepare Severely Calcified Coronary Lesions. (2022) (6)
Severe, resistant spasm of the left main coronary artery--a serious pitfall. (2000) (6)
Moxonidine Displays a Presynaptic Alpha‐2‐Adrenoceptor‐Dependent Synergistic Sympathoinhibitory Action at Imidazoline‐1 Receptors (2003) (6)
Selection of TAVI prostheses: do we really have the CHOICE? (2014) (6)
Effect of adjunctive treatment with tirofiban on troponin T elevation during stenting of critically stenosed aortocoronary saphenous vein grafts. (2005) (6)
Potentiation of potassium-evoked noradrenaline and neuropeptide Y co-release by cardiac energy depletion: role of calcium channels and sodium-proton exchange (1992) (6)
Carvedilol Versus Metoprolol in the Acute Phase of Myocardial Infarction: (2005) (6)
Acute and Long-Term Outcomes of Patients with Impaired Left Ventricular Systolic Function Undergoing Rotational Atherectomy: A Single-Center Observational Retrospective Study (2019) (6)
COMPARISON OF TWO SUTURE MEDIATED CLOSURE DEVICES FOR ACCESS SITE CLOSURE AFTER TRANSFEMORAL AORTIC VALVE IMPLANTATION (2015) (6)
Adenylyl Cyclase-Dependent Inhibition of Myocardial Norepinephrine Release by Presynaptic Adenosine A1-Receptors (2005) (6)
Real-world experience of drug-eluting stents in saphenous vein grafts compared to native coronary arteries: results from the prospective multicenter German DES.DE registry (2012) (6)
Statin effect on thrombin inhibitor effectiveness during percutaneous coronary intervention: a post-hoc analysis from the ISAR-REACT 3 trial (2011) (6)
Hemodynamic classification of paravalvular leakage after transcatheter aortic valve implantation compared with angiographic or echocardiographic classification for prediction of 1‐year mortality (2018) (6)
Transcatheter aortic valve implantation: technique, complications and perspectives (2014) (6)
Dual Mechanism of Action (2005) (6)
Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry. (2011) (6)
A rare, unreported complication during coronary rotational atherectomy. (2000) (6)
Outcomes of rotational atherectomy versus modified balloon angioplasty in severely calcified coronary lesions based on target lesion location: a post hoc analysis of the PREPARE-CALC randomised trial (2020) (5)
Clinical restenosis and its predictors after implantation of everolimus-eluting bioresorbable vascular scaffolds: results from GABI-R. (2017) (5)
Impact of Coronary Calcification on Clinical Outcomes After Implantation of Newer‐Generation Drug‐Eluting Stents (2021) (5)
Sunday, 26 August 2012 (2012) (5)
A HPLC-fluorescence detection method for determination of phosphatidic acid phosphohydrolase activity: application in human myocardium. (2008) (5)
Outcome of percutaneous coronary intervention with drug-eluting stents in unprotected left main versus non-left main native coronary artery disease: results from the prospective multicenter German DES.DE registry (2013) (5)
The AngioGuard: a simplified snare? (2004) (5)
Risk factors for early reocclusion and luminal renarrowing in patients with acute coronary syndromes treated by direct PTCA with provisional stenting (2000) (5)
Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome in Relation to Estimated Glomerular Filtration Rate. (2021) (5)
Fever and Inflammatory Response as Principal Manifestation of Chronic Aortic Type A Dissection (2004) (5)
Predictors of in-hospital adverse outcomes after rotational atherectomy: Impact of the target vessel SYNTAX score. (2020) (5)
Intravascular ultrasound-guided emergency coronary Palmaz-Schatz stent placement without post-procedural systemic anticoagulation. (1996) (5)
How should I treat dislocation of a TAVI SAPIEN prosthesis into the left ventricle? (2015) (5)
Termination of Ventricular Tachycardia with Antitachycardia Pacing after Ineffective Shock Therapy in an ICD Recipient with Hypertrophic Cardiomyopathy (2009) (5)
Coronary stenting with the sirolimus-eluting stent in patients with restenosis after intracoronary brachytherapy: results from the prospective multicentre German Cypher Stent Registry (2010) (5)
Complex vs. non-complex percutaneous coronary intervention with newer-generation drug-eluting stents: an analysis from the randomized BIOFLOW trials (2022) (5)
Effect of Gallopamil on Neutrophil Function: Experimental and Clinical Studies (1992) (5)
Dual Antithrombotic Therapy with Clopidogrel and Novel Oral Anticoagulants in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Real-world Study (2018) (5)
Volume–outcomes relationship in the Era of modern coronary intervention—results from the prospective multicenter German DES.DE Registry (2013) (5)
Comparison of bivalirudin and heparin in patients undergoing rotational atherectomy: a subanalysis of the randomised ROTAXUS trial. (2014) (4)
[Cellular sequelae of myocardial ischemia]. (1997) (4)
Treatment of coronary bifurcation lesions with drug-eluting stents: insights from the first phase of the prospective multicenter german drug-eluting stent registry. (2012) (4)
Extension of a Coronary Intramural Hematoma as a Complication of Early Percutaneous Coronary Intervention after Thrombolytic Therapy (2013) (4)
Comparison of long‐term clinical outcomes in multivessel coronary artery disease patients treated either with bioresoarbable polymer sirolimus‐eluting stent or permanent polymer everolimus‐eluting stent: 5‐year results of the CENTURY II randomized clinical trial (2019) (4)
Penetrating Atherosclerotic Ulcer of the Ascending Aorta: A Delayed Complication of Coronary Artery Bypass Surgery (2003) (4)
Clinical results with the Resolute zotarolimus-eluting stent in total coronary occlusions. (2015) (4)
Impact of target lesion location on procedural and angiographic outcomes of rotational atherectomy versus modified balloon angioplasty prior to drug-eluting stent implantation in severely calcified coronary lesions:a subgroup analysis of the PREPARE-CALC randomized trial. (2019) (4)
Effects of gabexate mesilate on the reactions of lipid metabolism in endotoxic shock. (1983) (4)
Outcomes after differential use of drug‐eluting stents in diabetic patients: 1‐Year results from the DES.DE (Drug‐Eluting Stent.DEutschland) registry (2010) (4)
[Coronary embolism with apical ballooning complicating electrical cardioversion--is it part of the apical ballooning syndrome? Case report and review of the literature]. (2006) (4)
INTERNATIONAL FIRST IN MAN TRIAL WITH A NOVEL DRUG ELUTING BALLOON IN PATIENTS PRESENTING WITH IN-STENT RESTENOSIS (PEPPER) (2011) (4)
TWO YEAR RESULTS FROM THE COMPARE-ACUTE TRIAL (2018) (4)
Effect of Aortic Regurgitation by Cardiovascular Magnetic Resonance After Transcatheter Aortic Valve Implantation. (2019) (4)
A unique pitfall in percutaneous coronary angioplasty of in‐stent restenosis: Guidewire passage out of the stent (2001) (4)
Feasibility and safety of minimal-contrast IVUS-guided rotational atherectomy for complex calcified coronary artery disease (2021) (4)
TCT-476 Angiographic and clinical analysis of 164 cases of longitudinal stent deformation: comparison of cases from a multicentre case series with cases identified from the MAUDE database (2013) (4)
First experience and validation of the extended early meets late (EEML) tool as part of the novel CARTO software HD COLORING (2020) (4)
Effect of angiotensin converting enzyme inhibitors on cardiac noradrenaline release. (1991) (4)
Cardiac involvement in hypereosinophilic syndromes detected by cardiac magnetic resonance imaging (2013) (3)
TCT-99 Valve thrombosis after transcatheter aortic valve replacement: incidence, characteristics and outcomes (2015) (3)
Role of angiotensin and sodium intake in cardiac noradrenaline release (1991) (3)
Clinical and angiographic outcome of patients with acute inferior myocardial infarction and right ventricular involvement treated with direct PTCA (2000) (3)
Antiplatelet vs. anticoagulation treatment after intracoronary Palmaz-Schatz stent placement in acute myocardial infarction — A prospective randomized trial (1996) (3)
Clinical and hemodynamic predictors of natriuretic peptide elevation among aortic valve disease patients. (2011) (3)
An unusual complication of metallic balloon shaft fracture during coronary angioplasty. (2001) (3)
Impact of calcified lesion complexity on the success of percutaneous coronary intervention with upfront high-speed rotational atherectomy or modified balloons - A subgroup-analysis from the randomized PREPARE-CALC trial. (2021) (3)
Polymer-Free Drug-Coated Coronary Stents Are Cost-Effective in Patients at High Bleeding Risk: Economic Evaluation of the LEADERS FREE Trial. (2018) (3)
The sirolimus-eluting coronary stent in clinical practice: impact of direct stenting versus stenting with balloon pre-dilatation. (2007) (3)
Outcomes of patients treated with a biodegradable-polymer sirolimus-eluting stent versus durable-polymer everolimus-eluting stents after rotational atherectomy (2021) (3)
Calcitonin gene-related peptide does not interact with sympathetic activity in myocardial ischemia (2005) (3)
Sirolimus-eluting stent treatment for complex proximal left anterior descending artery stenoses: 7-month clinical and angiographic results. (2005) (3)
Psychosocial and physical long-term outcome in patients with a history of takotsubo cardiomyopathy or myocardial infarction - a multi-centered case control study (2020) (3)
Rotational atherectomy of a stent-jailed septal perforator: a good verdict for the prisoner. (2001) (3)
Monday, 27 August 2012 (2012) (3)
Symptomatic abnormal vessel wall reaction after implantation of the first generation sirolimus-eluting stent: a case series. (2012) (3)
Results of Endoaneurysmorrhaphy: Does the Location of the Aneurysm Matter? (2003) (3)
Combined percutaneous coronary intervention and transcatheter aortic valve implantation in cardiogenic shock. (2013) (3)
Efficacy and Safety of Ticagrelor Versus Prasugrel in Women and Men with Acute Coronary Syndrome: A Pre-specified, Sex-Specific Analysis of the ISAR-REACT 5 Trial (2021) (3)
The fate of incomplete scaffold apposition of everolimus-eluting bioresorble scaffolds: A serial optical coherence tomography analysis. (2017) (3)
Clinical outcomes in unselected patients treated with the PROMUS Element platinum‐chromium, everolimus‐eluting stent: Final five‐year results from the PE PROVE Study (2018) (3)
Prognostic value of bleeding after percutaneous coronary intervention in patients with diabetes. (2014) (3)
Simvastatin and Ezetimibe in Addition to Nonpharmacological Risk Factor Modification for Achieving New Low-Density Lipoprotein Cholesterol Targets (2008) (3)
Early neoatherosclerosis after bioresorbable vascular scaffold implantation: insights from optical coherence tomography. (2016) (2)
Common Features of Neuropeptide Y and Noradrenaline Release in Guinea Pig Heart (1990) (2)
TCT-737 BIOFLOW-III an all comers registry with a Sirolimus Eluting Stent, Presentation of Five Year Target Lesion Failure Data (2013) (2)
Predictors of acute scaffold recoil after implantation of the everolimus-eluting bioresorbable scaffold: an optical coherence tomography assessment in native coronary arteries (2017) (2)
The Glider registry (2013) (2)
A Unique Complication During Coronary Angiography: Peripheral Embolism by Selective Right Coronary Engagement (2001) (2)
Twelve-month clinical outcomes in patients with acute coronary syndrome undergoing complex percutaneous coronary intervention: insights from the ISAR-REACT 5 trial. (2021) (2)
Unique effects of carvedilol on noradrenaline release in the human heart (2002) (2)
Percutaneous aortic valve replacement: results update, future trends and new challenges (2009) (2)
Clinical utility of a predictive model for paravalvular aortic regurgitation after transcatheter aortic valve implantation with a self-expandable prosthesis (2017) (2)
Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome Undergoing Complex Percutaneous Coronary Intervention (2021) (2)
Fractional Flow Reserve in Acute Myocardial Infarction: A Guide for Non-Culprit Lesions? (2015) (2)
Bioflow-III: one year target lesion failure data of an all-comers registry with a drug eluting stent (2013) (2)
Rotational atherectomy of calcified coronary lesions: current practice and insights from two randomized trials (2022) (2)
Polymer-free drug-coated vs. bare-metal coronary stents in patients undergoing non-cardiac surgery: a subgroup analysis of the LEADERS FREE trial (2020) (2)
Correlation and Relative Prognostic Value of Fractional Flow Reserve and Pd/Pa of Nonculprit Lesions in ST-Segment-Elevation Myocardial Infarction. (2022) (2)
TCT-173 Safety and Clinical Performance of the Drug Eluting Osiro Stent in the Treatment of Subjects With Single De Novo Coronary Artery Lesions-II (BIOFLOW-II) (2013) (2)
Interventional Cardiology 4-Year Clinical Outcomes and Predictors of Repeat Revascularization in Patients Treated With New-Generation Drug-Eluting Stents A Report From the RESOLUTE All-Comers Trial ( A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutan (2)
[The sympathetic nervous system and coronary heart disease]. (2008) (2)
Prognostic value of haemoglobin drop in patients with acute coronary syndromes (2021) (2)
Endothelial Adenosine Receptors Modulate Leukocyte Adhesion: Relevance for Myocardial Reperfusion Damage (1995) (2)
Multicenter comparison of latest-generation balloon-expandable versus self-expanding transcatheter heart valves: Ultra versus Evolut. (2022) (2)
Human Cardiac Tissue (2005) (2)
Adrenergic activation of cardiac phospholipase D: role of alpha(1)-adrenoceptor subtypes. (2002) (2)
Early Post-Operative Haemodynamic and Neurohumoral Follow-Up After Endoaneurysmorrhaphy (2001) (2)
Percutaneous MitraClip therapy: Early and one year results from the ACCESS-EU prospective, multicenter, non randomized post-approval study in Europe (2014) (2)
Evidence for nonexocytotic noradrenaline release in human cardiac tissue (1990) (2)
Individual patient data analysis of the BIOFLOW study program comparing safety and efficacy of a bioresorbable polymer sirolimus eluting stent to a durable polymer everolimus eluting stent (2019) (2)
Effect of Gallopamil on Myocardial Ischaemia During Percutaneous Transluminal Coronary Angioplasty (2012) (2)
Digitalis glycosides enhance cardiac noradrenaline release by a dual mechanism of action (1990) (1)
Nine‐month results of the BIOHELIX‐I clinical trial study: Evaluation of the PRO‐Kinetic Energy cobalt chromium bare‐metal stent system (2018) (1)
Efficacy and safety of ticagrelor versus prasugrel in smokers and nonsmokers with acute coronary syndromes. (2021) (1)
Desipramine Inhibits the Nicotine-Induced Exocytosis in Rat Phaeochromocytoma Cells (PC12) (1991) (1)
TCT-205 One year outcomes of percutaneous coronary intervention with a modern drug-eluting stent in patients with moderate and severe coronary calcification: A pooled analysis from the Nobori-2 and e-Nobori all-comer registries (2013) (1)
[The sympathetic-adrenergic system in heart failure]. (1996) (1)
Ablation Therapy as Management of Typical Atrial Flutter in the Early Period After Cardiac Surgery (2021) (1)
Angiographic predictors of unplanned rotational atherectomy in complex calcified coronary artery disease: a pooled analysis from the randomised ROTAXUS and PREPARE-CALC trials. (2021) (1)
Effect of nicotine on biological systems (1991) (1)
TCT-442 Predictors of mortality in patients with acute myocardial infarction complicated by cardiogenic shock: Can we improve outcomes by proper timing of mechanical circulatory support? (2013) (1)
Ticagrelor or prasugrel in patients with acute coronary syndrome in relation to glomerular filtration rate (2021) (1)
Features of neuropeptide Y and noradrenaline co-release in guinea-pig heart (1990) (1)
The target vessel SYNTAX score: A novel pre-procedural predictor for contrast-induced acute kidney injury after rotational atherectomy. (2022) (1)
Lithoplasty-Facilitated Proximal Cap Penetration of a Calcified Chronic Total Occlusion Coronary Lesion (2022) (1)
Long-Term Clinical and Echocardiographic Outcome After TAVR With the Mechanically Expanding Lotus Valve. (2022) (1)
TCT-26 Predictors of Bailout Rotational Atherectomy in Patients With Complex Calcified Coronary Artery Disease: A Pooled Analysis From the Randomized ROTAXUS and PREPARE-CALC Trials (2019) (1)
Intracoronary beta radiation for in-stent restenosis in a patient with percutaneously treated hypertrophic cardiomyopathy and coronary artery disease. (2002) (1)
Ablation of typical atrial flutter as therapeutic component in carcinoid heart disease: a case report (2022) (1)
Transcatheter Aortic Valve Implantation With the Third Generation Balloon-Expandable Bioprosthesis in Patients With Severe Landing Zone Calcium. (2019) (1)
Prediction of risk for bleeding, myocardial infarction and mortality after percutaneous coronary intervention in patients with acute coronary syndromes (2022) (1)
Assessment of Impact of Patient Recruitment Volume on Risk Profile, Outcomes, and Treatment Effect in a Randomized Trial of Ticagrelor Versus Prasugrel in Acute Coronary Syndromes (2021) (1)
Modulation of potassium-evoked exocytotic co-release of noradrenaline and neuropeptide Y by cardiac energy depletion (1991) (1)
No difference in 30-day outcome and quality of life in transradial versus transfemoral access – Results from the German Austrian ABSORB registry (GABI-R) (2021) (1)
Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome and High Bleeding Risk (2022) (1)
Reply: Outcomes After Transcatheter Aortic Valve Replacement With Balloon-Expandable Versus Self-Expandable Valves: CHOICE Trial Results. (2016) (1)
TCT-544 Case Series of 100 cases of longitudinal stent Deformation (2012) (1)
Tuesday, 28 August 2012 (2012) (1)
Plasma N-terminal pro-BNP predicts the occurrence of major clinical events in severe chronic heart failure: results of a substudy of the COPERNICUS trial (2002) (1)
TCT-106 FFR in Nonculprits in STEMI: A Substudy of the COMPARE-ACUTE Trial (2019) (1)
Effects of Intracoronary Low‐Dose Enalaprilat on Ventricular Repolarization Dynamics After Direct Percutaneous Intervention for Acute Myocardial Infarction (2007) (1)
Interactions of adenosine with sympathetic neurotransmission: protective effect in myocardial ischemia. (1996) (1)
Everolimus eluting bioresorbable vascular scaffolds in patients with acute coronary syndromes: Two‐year results from the German‐Austrian ABSORB registry (2021) (1)
Percutaneous Coronary Intervention vs Medical Therapy for Coronary Lesions With Positive Fractional Flow Reserve (FFR) but Preserved Pressure-Bounded Coronary Flow Reserve (CFR): A Substudy of the Randomized Compare-Acute Trial. (2021) (1)
Alpha -adrenergic receptor-mediated increase in the mass of phosphatidic (1999) (1)
A novel strategy to overcome resistance in stent placement at lesion site after adequate predilatation. (2000) (1)
Comparison between treatment of “established” versus complex “off-label” coronary lesions with Absorb® bioresorbable scaffold implantation: results from the GABI-R® registry (2019) (1)
Neointimal coverage of overlapping everolimus-eluting bioresorbable scaffolds: An optical coherence tomography study in native coronary arteries. (2015) (1)
Impact of Revascularization Completeness on Outcomes of Patients with Coronary Artery Disease Undergoing Transcatheter Aortic Valve Replacement (2019) (1)
Preadmission antiplatelet therapy and treatment effect of ticagrelor versus prasugrel in patients with acute coronary syndromes - a subgroup analysis of the ISAR-REACT 5 trial. (2022) (1)
TCT-448 BIOTRONIK-Safety and Clinical Performance of the Drug Eluting Orsiro Stent in the Treatment of Subjects With Single De Novo Coronary Artery Lesions-II (BIOFLOW-II) - 4 Year Clinical Results. (2014) (1)
[Presynaptic regulation of co-release of neuropeptide Y and noradrenaline induced by electrical stimulation of the sympathetic nerve in guinea pig heart]. (1991) (1)
[Antiplatelet therapy and anticoagulation in acute coronary syndrome: current evidence]. (2014) (1)
39 Long-term outcomes of a randomized comparison of drug-eluting stents versus bare metal stents in saphenous vein graft lesions – 5-year follow-up of the isar-cabg trial (2017) (1)
Prior Myocardial Infarction and Treatment Effect of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndromes ‐ A Post‐hoc Analysis of the ISAR‐REACT 5 Trial (2022) (1)
Recovery of stimulation-evoked noradrenaline release during reperfusion after acute ischemia in rat hearts (1992) (1)
Hypereosinophile Syndrome (2012) (1)
Hemodynamic performance of the balloon-expandable SAPIEN 3 valve as assessed by cardiac magnetic resonance. (2020) (1)
A1 adenosine receptors and muscarinic cholinoceptors in myocardial ischemia (1996) (1)
Adverse childhood experiences and the structure of personality in patients with takotsubo syndrome versus myocardial infarction (2020) (1)
MY APPROACH to management of aortic stenosis in the elderly. (2016) (1)
Hybrid Coronary Percutaneous Treatment with Metallic Stents and Everolimus-Eluting Bioresorbable Vascular Scaffolds: 2-Years Results from the GABI-R Registry (2019) (0)
Imaging-Guided Transcatheter Aortic Valve Replacement and Percutaneous Coronary Intervention in Decompensated Severe Aortic Stenosis with Acute Renal Impairment (2021) (0)
24 A non-randomized comparison of two paclitaxel-coated balloons for the treatment of coronary in-stent restenosis (2017) (0)
Ticagrelor or prasugrel in patients with acute coronary syndrome with off-hour versus on-hour presentation: a subgroup analysis of the ISAR-REACT 5 trial (2022) (0)
Drug-eluting versus bare-metal stents in saphenous vein graft lesions – Author's reply (2012) (0)
Prognostic Value of Quantitative Flow Ratio After Successful Percutaneous Coronary Intervention for Chronic Total Occlusion (2022) (0)
Nicotine-induced noradrenaline and neuropeptide Y release in normoxic and anoxic guinea pig heart (1990) (0)
[Adenosine--an endogenous protective substance in the heart]. (2008) (0)
Left ventricular remodelling and prosthetic valve function after transcatheter aortic valve implantation: A serial cardiac magnetic resonance imaging study (2015) (0)
High-speed rotational atherectomy versus modified balloons for plaque preparation of severely calcified coronary lesions: two-year outcomes of the randomised PREPARE-CALC trial. (2022) (0)
Cost-Savings In Process Innovations; A Case Example In Myocardial Infarction Patients (2017) (0)
TCT-115 Complex Versus Noncomplex Percutaneous Coronary Intervention With Newer-Generation Drug-Eluting Stents: An Analysis From the Randomized BIOFLOW Trials (2021) (0)
Valvular and Congenital Heart Disease Early hemodynamic and neurohormonal response after transcatheter aortic valve implantation (2010) (0)
ComparisonofBalloon-ExpandablevsSelf-expandableValves inPatientsUndergoingTranscatheterAorticValveReplacement The CHOICE Randomized Clinical Trial (2014) (0)
Sirolimus-eluting stent treatment as buffer for inflamed lesions identified by serum marker estimation. The STABILISE pilot study. (2007) (0)
Sympathetic activity during coronary balloon angioplasty (1991) (0)
Abstract 18127: The Relationship Between Nonuniform Strut Distribution and Neointimal Coverage After Everolimus-eluting Bioresorbable Scaffolds Implantation (2015) (0)
Predictors of scaffold failure and impact of optimized scaffold implantation technique on outcome: Results from the German‐Austrian ABSORB RegIstRy (2021) (0)
Abstract 13910: The Impact of Peripheral Arterial Disease on Early Outcome After Transcatheter Aortic Valve Implantation. Results From the German TAVI Registry. (2011) (0)
TCT-230 Culprit Lesion Location and Outcome in Patients with Cardiogenic Shock Complicating Myocardial Infarction: A Substudy of the IABP-SHOCK II-Trial (2015) (0)
Prospective randomized trial of antiplatelet vs. anticoagulation treatment after intracoronary Palmaz-Schatz stent placement-6-month follow-up (1996) (0)
Thoracic peridural block in experimental endotoxin shock. (1987) (0)
Effect of ACE-inhibitor Ramiprilat and AT1-receptor Antagonist Candesartan on Cardiac Norepinephrine Release: Comparison Between Ischemic and Nonischemic Conditions (2002) (0)
Abstract 3031: Repeat Revascularisation following Multivessel Sirolimus-eluting Stent Implantation: Indications and Long-term Follow-up From the Arterial Revascularisation Therapies Study Part 2 (ARTS-II) (2008) (0)
CRT-700.07 Nine-Month RESULTS Of The BIOHELIX-I Clinical Trial Study: Evaluation Of The PRO-Kinetic Energy Cobalt Chromium Bare-Metal Stent (2017) (0)
[Far from verified: the infection hypothesis of arteriosclerosis. Antibiotics for heart patients? (interview by Dipl. Biol. Waltraud Paukstadt)]. (2001) (0)
TCT-697 Relationship between the degree of device oversizing and clinical outcomes in patients treated with transcatheter aortic valve replacement using balloon-expandable or self-expanding valves: Insights from the randomized CHOICE trial (2015) (0)
Significant aortic regurgitation after transfemoral aortic valve implantation: patients' gender as independent risk factor. (2015) (0)
CRT-155 Bioflow-III an All Comers Registry with a Sirolimus Eluting Stent- One Year Safety and Performance Results (2015) (0)
Incidence and predictors of unplanned non-target lesion revascularization after drug-eluting stent implantation: insights from a pooled analysis of the global RESOLUTE clinical trial program (2013) (0)
[Coronary heart disease -- significance of coronary intervention]. (2007) (0)
TCT-753 Impact of bivalirudin on peri-procedural events in patients undergoing rotational atherectomy: a subanalysis of the randomized ROTAXUS trial (2012) (0)
[Cardiac sympathetic nerve activity in ischemic heart failure]. (1998) (0)
Access route and clinical outcomes after ticagrelor versus prasugrel in patients with acute coronary syndrome undergoing invasive treatment strategy. (2022) (0)
Guide wire inducable reopening of the infarct related artery in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous intervention: a marker of low mortality (2002) (0)
Quantitative assessment of prosthetic valve regurgitation after TAVI by angiography and cardiac magnetic resonance imaging (2017) (0)
Di V erential e V ects of defibrillation on systemic and cardiac sympathetic activity (1998) (0)
Circulation: Cardiovascular Interventions (2022) (0)
Multicenter comparison of transcatheter aortic valve implantation with the self-expanding ACURATE neo2 versus Evolut PRO transcatheter heart valves. (2023) (0)
CRT-100.68 Prognostic Value of Quantitative Flow Ratio After Successful Percutaneous Coronary Intervention for Chronic Total Occlusion (2022) (0)
TCT-403 Procedural, In-Hospital And One-Year Outcome Of Provisional Versus Planned Rotational Atherectomy In Complex Calcified Coronary Lesions (2015) (0)
1625prosthetic valve regurgitation after transcatheter aortic valve implantation with new-generation devices compared to surgical aortic valve replacement–a cardiac magnetic resonance imaging flow measurement analysis (2016) (0)
Adenosine and catecholamines (1991) (0)
Editorial on: Human cardiac phospholipase D activity is tightly controlled by phosphatidylinositol 4,5-bisphosphate, T. Kurz, D. Kemken, (2004) (0)
P1251Percutaneous coronary intervention versus medical therapy for coronary lesions with positive fractional flow reserve (FFR) but preserved coronary flow reserve (CFR). A substudy of the COMPARE-ACUTE (2019) (0)
[Intermediate term clinical results after endoaneurysmorrhaphy in left ventricular aneurysm]. (2000) (0)
Neointimal response to everolimus-eluting bioresorbable scaffolds implanted at bifurcating coronary segments: insights from optical coherence tomography (2017) (0)
Modulation of protein kinase C activity and ventricular fibrillation in acute myocardial ischemia (1992) (0)
Temporal changes in left ventricular function and paravalvular aortic regurgitation after transcatheter aortic valve implantation: a cardiac magnetic resonance imaging study (2012) (0)
P2260Long-term durability and hemodynamic performance of a self-expanding transcatheter heart valve beyond 5 years after implantation: a prospective observational study applying the standardized definition (2018) (0)
Radiofrequency ablation of typical atrial flutter with access through the azygos vein in a patient with heterotopia utilizing high-density electroanatomic mapping (2018) (0)
TCT-908 Gender-related differences in baseline characteristics and clinical outcome of transcatheter aortic valve implantation (2012) (0)
Nicotine-Induced Release of Noradrenaline and Neuropeptide Y in the Heart: Dependence on Calcium, Potassium, and pH (1991) (0)
Short Communication Norepinephrine release is reduced in cardiac tissue of Type 2 diabetic patients (2003) (0)
TCT-42 Polymer-Free Drug-Coated Versus Bare-Metal Coronary Stents in Patients Undergoing Noncardiac Surgery: A Subgroup Analysis of the LEADERS FREE Trial (2019) (0)
[Microorganisms and coronary heart disease. Do antibiotics protect against cardiac events?]. (2002) (0)
Reduction of myocardial infarct size by a HMG CoA-reductase inhibitor in normocholesterolemic rats (2002) (0)
1154FFR guided acute complete revascularization versus culprit lesion only treatment in patients presenting with STEMI and multi vessel disease; final 3-year outcome data from Compare-Acute trial (2019) (0)
Persisting troponin T release indicates irreversible myocardial cell damage (1992) (0)
TCT-193 The Correlation and Relative Prognostic Value of FFR and Pd/Pa of Nonculprit Lesions in STEMI (2021) (0)
1203Typical atrial flutter is a manifestation of previously silent coronary artery disease (2019) (0)
[Myocardial rupture after myocardial infarct]. (1990) (0)
Beta-adrenergic stimulation accelerates endogenous adenosine release in cardiac energy deficiency (1990) (0)
1280Long-term impact of prosthetic valve regurgitation after transcatheter aortic valve implantation: a 5-year follow-up analysis from the German TAVI registry (2017) (0)
Efficacy and safety of ticagrelor versus prasugrel in smokers and nonsmokers with acute coronary syndromes (2021) (0)
Sex-specific Inequalities in the Treatment of Severely Calcified Coronary Lesions: A Sub-analysis of the PREPARE-CALC Trial (2023) (0)
Ischemia-induced noradrenaline release and ventricular fibrillation in isolated rat heart (1992) (0)
TCT-596 Pantera Lux Drug Coated Balloon: Twelve-Month Results On The Diabetics Subgroup Of The International DELUX Registry (2012) (0)
Antiplatelet Therapy in Acute Coronary Syndromes without Persistent ST-Segment Elevation (2001) (0)
Typical atrial flutter but not fibrillation predicts coronary artery disease in formerly healthy patients. (2021) (0)
1118-80 Effects of intracoronary low-dose enalaprilat on QT dynamicity in patients undergoing direct percutaneous coronary intervention for acute myocardial infarction (2004) (0)
Quality of life of patients with coronary heart disease treated with the bioresorbable vascular scaffold (ABSORB™): 2-year results from the GABI-R-registry (2022) (0)
3122Longterm comparative efficacy of drug-eluting stents versus bare metal stents in saphenous vein graft lesions: 5-year clinical follow-up of a randomized trial (2017) (0)
Side Branch Late Thrombosis After Left Main Coronary Artery Crossover Stenting (2022) (0)
TCT-522 Impact of Strut Distribtuion on Neointimal Coverage of Everolimus-Eluting Bioresorbable Scaffolds: An Optical Coherence Tomography Study (2015) (0)
Compression of the left coronary arteries by a large pseudoaneurysm as a late complication after surgical treatment of aortic valve endocarditis. (2010) (0)
Long-Term Outcomes after Rotational Atherectomy for Calcified Chronic Total Occlusion versus Nonchronic Total Occlusion Coronary Lesions (2022) (0)
Impact of Prosthetic Valve Regurgitation Assessed by Echocardiography and Magnetic Resonance Imaging on Long-Term Clinical Outcomes after TAVR (2022) (0)
TCT-1 High number of angiographic significant lesions are FFR negative in STEMI patients with multi-vessel disease: preliminary insight into the COMPARE-ACUTE trial (2015) (0)
Reply: The CHOICE Randomized Clinical Trial. (2020) (0)
Studies on the effects of vasodilating agents in addition to volume therapy in endotoxic shock. (1982) (0)
Response to A Haverich’s letter (2008) (0)
Effect of strut distribution on neointimal coverage of everolimus-eluting bioresorbable scaffolds: an optical coherence tomography study (2017) (0)
“Impossible objects” in a life‐threatening crisis: A study of patients suffering from adverse childhood experiences and myocardial infarction (2020) (0)
Combination of Single-Chain Urokinase-Type Plasminogen Activator and Recombinant Tissue-Type Plasminogen Activator in Acute Myocardial Infarction (2005) (0)
4285Impact of prosthetic valve regurgitation quantified by cardiac magnetic resonance imaging on long-term mortality after TAVI (2018) (0)
Association between Platelet Count and Treatment Effect of Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes (2022) (0)
Two-year Optical Coherence Tomography Findings after Balloon-Only Treatment of Bioresorbable Scaffold Restenosis in a Calcified Coronary Lesion: A Case Report (2016) (0)
Response to Letter Regarding Article, “Validation of the Bleeding Academic Research Consortium Definition of Bleeding in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention” (2012) (0)
Intra-Aortic Balloon Counterpulsation in Cardiogenic Shock Complicating Acute Myocardial Infarction: Does the Timing Matter? (2010) (0)
Patients with higher-atherothrombotic risk vs. lower-atherothrombotic risk undergoing coronary intervention with newer-generation drug-eluting stents: an analysis from the randomized BIOFLOW trials. (2023) (0)
Dual effect of nicotine on cardiac noradrenaline release during energy depletion of the heart (1992) (0)
Modulated neurotransmission in rat, guinea pig, and human cardiac tissue Effect of myocardial ischemia on stimulation-evoked noradrenaline release. (2011) (0)
Impact of coronary calcification on outcomes after ABSORB scaffold implantation: insights from the GABI-R registry (2020) (0)
Prognostic Value of HFA-PEFF Score in Patients Undergoing Transcatheter Aortic Valve Implantation (2022) (0)
EARLY HEMODYNAMIC AND NEUROHORMONAL RESPONSE AFTER PERCUTANEOUS VERSUS SURGICAL AORTIC VALVE REPLACEMENT (2010) (0)
TCT-14: A Single Center, Real World Experience of Drug-Eluting Balloon Use in the Treatment of Instent Restenosis and Diffuse Coronary Artery Disease (2016) (0)
TCT-79 Multimodality Assessment of Prosthetic Valve Regurgitation to Predict Reverse Cardiac Remodeling and Long-Term Clinical Outcomes After Transcatheter Aortic Valve Replacement: Results From the Prospective POST-TAVI Registry (2019) (0)
TCT-417 Comparative efficacy of two paclitaxel-coated balloons with different excipient coatings in patients with coronary in-stent restenosis (2017) (0)
P1484The modified natural history of mitral regurgitation in patients undergoing transcatheter aortic valve implantation (2018) (0)
648 Drug treatment of acute coronary syndrome patients / Targeting very late restenosis (0)
Comparison of direct PCI and front-loaded tissue plasminogen activator for the treatment of patients with right ventricular infarction - a matched-pairs analysis on 174 patients (2000) (0)
[Interactions of adenosine with sympathetic neurotransmission in the heart]. (1996) (0)
Body mass index and efficacy and safety of ticagrelor versus prasugrel in patients with acute coronary syndromes. (2021) (0)
Body mass index and efficacy and safety of ticagrelor versus prasugrel in patients with acute coronary syndromes (2021) (0)
Structural Aortic Regurgitation After Transcatheter Aortic Valve Implantation With Balloon-and Self-Expandable Prostheses (0)
The Effect of a Prasugrel- versus a Ticagrelor-based Strategy on Total Ischemic and Bleeding Events in Patients with Acute Coronary Syndromes. (2022) (0)
PREDICTORS OF SIGNIFICANT PARAVALVULAR REGURGITATION AFTER TRANSCATHETER AORTIC VALVE IMPLANTATION: RESULTS FROM THE PROSPECTIVE MULTICENTER GERMAN AORTIC VALVE REGISTRY (2010) (0)
[Intracoronary stent implantation and left ventricular function in primary PTCA in acute myocardial infarct]. (2000) (0)
467FFR guided acute complete revascularization versus culprit lesion only treatment in patients presenting with STEMI; 3-year cost-analysis data from COMPARE-ACUTE trial (2019) (0)
Comparison of the Edwards SAPIEN XT and the Medtronic CoreValve prosthesis (2014) (0)
Metabolic and sympathetic effects of intracoronary gallopamil during coronary balloon angioplasty (1992) (0)
Abstract 3035: Sirolimus-eluting Stents Compared With Bare Metal Stents or Coronary Artery Bypass Grafting in Patients with Multivessel Disease including Involvement of the Proximal Left Anterior Descending Artery: Analysis of the Arterial Revascularization Therapies Study part 2 (ARTS-II) (2008) (0)
Transcatheter aortic valve implantation: technique, complications and (2014) (0)
Sirolimus-Eluting Stent Treatment at High-Volume Centers Confers Lower Mortality at 6-Month Follow-Up Results From the Prospective Multicenter German Cypher Registry Interventional Cardiology (2009) (0)
TCT-628 Safety and Efficacy of Everolimus-Eluting Bioresorbable Vascular Scaffolds in Complex Coronary Lesions (2014) (0)
TCT-244 Impact of Different Methods of Lesion Preparation on Side Branches in Calcified Coronary Bifurcations: A Subanalysis of the Randomized PREPARE-CALC Trial (2019) (0)
Bioprosthetic valves for transcatheter aortic valve replacement--reply. (2014) (0)
[Cypher stent: the German registry. Results of the German prospective multicenter registry on Cypher]. (2004) (0)
TCT-595 Pantera Lux Drug Coated Balloon: Twelve-Month Results On 1'064 Patients Of The International DELUX Registry (2012) (0)
Risk and Benefit of Prolonged Dual Antiplatelet Therapy After Drug-eluting Coronary Stents : Primary Endpoint Results from the Dual Antiplatelet Therapy Study (2014) (0)
Combined rotational atherectomy and cutting balloon angioplasty prior to drug‐eluting stent implantation in severely calcified coronary lesions: The PREPARE‐CALC‐COMBO study (2022) (0)
[Adenosine in the heart: an endogenous protective system]. (1994) (0)
Acute coronary syndromes Prasugrel plus bivalirudin vs . clopidogrel plus heparin in patients with ST-segment elevation myocardial infarction (0)
Abstract 18158: Neointimal Coverage of Overlapping Everolimus-eluting Bioresorbable Scaffolds: An Optical Coherence Tomography Study in Native Coronary Arteries (2015) (0)
TCT-536 Neointimal Response to Everolimus-Eluting Bioresorbable Scaffolds Implanted at Bifurcating Coronary Segments: Insights from Optical Coherence Tomography (2015) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Gert H. Richardt?

Gert H. Richardt is affiliated with the following schools:

Technical University of Munich
University of Barcelona
Heidelberg University

Gert H. Richardt's Academic­Influence.com Rankings

Gert H. Richardt's Degrees

Why Is Gert H. Richardt Influential?

Gert H. Richardt's Published Works

Published Works

What Schools Are Affiliated With Gert H. Richardt?

Gert H. Richardt's AcademicInfluence.com Rankings